[Treatment of primary tuberculosis].
D000284:Administration, Oral; D000328:Adult; D000636:Aminosalicylic Acids / Q000627:therapeutic use; D000917:Antibody Formation; D000995:Antitubercular Agents / Q000627:therapeutic use*; D001500:BCG Vaccine; D002648:Child; D002675:Child, Preschool; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000627:therapeutic use; D005000:Ethionamide / Q000627:therapeutic use; D006801:Humans; D007111:Immunity, Cellular; D007223:Infant; D007538:Isoniazid / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D013307:Streptomycin / Q000627:therapeutic use; D014376:Tuberculosis / Q000188:drug therapy*; D014388:Tuberculosis, Lymph Node / Q000188:drug therapy; D014397:Tuberculosis, Pulmonary / Q000276:immunology
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D001500:BCG Vaccine; D004977:Ethambutol; D005000:Ethionamide; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin
Traitement de la tuberculose primaire.